Status:
COMPLETED
Modulating Brain Activity to Improve Goal-directed Physical Activity in Older Adults
Lead Sponsor:
Hebrew SeniorLife
Conditions:
Aging
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Although the majority of older adults are aware of the compelling evidence that regular exercise is critical to the maintenance of health into old age, most do not meet recommendations for daily exerc...
Eligibility Criteria
Inclusion
- Must live within subsidized housing in the Boston area
- Self-report of exercising, on average, less than 150 minutes of at least moderate-intensity exercise per week, as determined by phone-screen completion of the International Physical Activity Questionnaire-Short Form (IPAQ short)
Exclusion
- An inability to ambulate without the assistance of another person (canes or walkers allowed)
- Self-report of physician-diagnosed dementia, more than moderate cognitive impairment defined as a Montreal Cognitive Assessment (MoCA) score \<21, or an inability to understand the study protocol as determined by study staff
- A clinical history of stroke, Parkinson's disease or parkinsonian syndromes, multiple sclerosis, normal pressure hydrocephalus or other movement disorder affecting gait
- Any report of severe lower-extremity arthritis or physician-diagnosis of peripheral neuropathy
- Use of antipsychotics, anti-seizure, benzodiazepines, or other neuroactive medications
- Severe depression defined by a Geriatric Depression Scale score greater than 11
- Any report or physician-diagnosis of schizophrenia, bipolar disorder or other psychiatric illness
- Any unstable medical condition
- Resting systolic blood pressure is higher than 180 mmHg
- Contraindications tor tDCS, including reported seizure within the past two years, use of neuro-active drugs, self-reported presence of specific implanted medical devices (e.g., deep brain stimulator, medication infusion pump, cochlear implant, pacemaker, etc.), or the presence of any active dermatological condition, such as eczema, on the scalp
Key Trial Info
Start Date :
February 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 3 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04278560
Start Date
February 12 2020
End Date
November 3 2022
Last Update
May 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hebrew Rehabilitation Center
Roslindale, Massachusetts, United States, 02131